Literature DB >> 35899241

Portal pressure reductions induced by nonselective beta-blockers improve outcomes and decrease mortality in patients with cirrhosis with and without ascites.

Laura Turco1, Guadalupe García-Tsao2,3.   

Abstract

Content available: Audio Recording.
© 2022 American Association for the Study of Liver Diseases.

Entities:  

Year:  2022        PMID： 35899241      PMCID： PMC9306434          DOI： 10.1002/cld.1210

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  14 in total

1.  Cardiodynamic state is associated with systemic inflammation and fatal acute-on-chronic liver failure.

Authors:  Michael Praktiknjo; Sofia Monteiro; Josephine Grandt; Nina Kimer; Jan L Madsen; Mikkel P Werge; Peter William; Maximilian J Brol; Laura Turco; Robert Schierwagen; Johannes Chang; Sabine Klein; Frank E Uschner; Christoph Welsch; Richard Moreau; Filippo Schepis; Flemming Bendtsen; Lise L Gluud; Søren Møller; Jonel Trebicka
Journal:  Liver Int       Date:  2020-03-30       Impact factor: 5.828

2.  Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis.

Authors:  Laura Turco; Candid Villanueva; Vincenzo La Mura; Juan Carlos García-Pagán; Thomas Reiberger; Joan Genescà; Roberto J Groszmann; Barjesh C Sharma; Carlo Merkel; Christophe Bureau; Edilmar Alvarado; Juan Gonzalez Abraldes; Agustin Albillos; Rafael Bañares; Markus Peck-Radosavljevic; Salvador Augustin; Shiv K Sarin; Jaime Bosch; Guadalupe García-Tsao
Journal:  Clin Gastroenterol Hepatol       Date:  2019-06-05       Impact factor: 11.382

Review 3.  Portal Hypertension: Pathogenesis and Diagnosis.

Authors:  Laura Turco; Guadalupe Garcia-Tsao
Journal:  Clin Liver Dis       Date:  2019-11       Impact factor: 6.126

Review 4.  Clinical states of cirrhosis and competing risks.

Authors:  Gennaro D'Amico; Alberto Morabito; Mario D'Amico; Linda Pasta; Giuseppe Malizia; Paola Rebora; Maria Grazia Valsecchi
Journal:  J Hepatol       Date:  2017-10-27       Impact factor: 25.083

5.  β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.

Authors:  Càndid Villanueva; Agustín Albillos; Joan Genescà; Joan C Garcia-Pagan; José L Calleja; Carles Aracil; Rafael Bañares; Rosa M Morillas; María Poca; Beatriz Peñas; Salvador Augustin; Juan G Abraldes; Edilmar Alvarado; Ferran Torres; Jaume Bosch
Journal:  Lancet       Date:  2019-03-22       Impact factor: 79.321

6.  Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease.

Authors:  Octavi Bassegoda; Pol Olivas; Laura Turco; Mattias Mandorfer; Miquel Serra-Burriel; Luis Tellez; Wilhelmus Kwanten; Alexia Laroyenne; Oana Farcau; Edilmar Alvarado; Lucile Moga; Elise Vuille-Lessard; Jose Ignacio Fortea; Luis Ibañez; Giulia Tosetti; Thomas Vanwolleghem; Hélène Larrue; Diego Burgos-Santamaría; Horia Stefanescu; Rafael Paternostro; Annalisa Cippitelli; Sabela Lens; Salvador Augustin; Elba Llop; Wim Laleman; Jonel Trebicka; Johannes Chang; Helena Masnou; Alexander Zipprich; Francesca Miceli; Georg Semmler; Xavier Forns; Massimo Primignani; Rafael Bañares; Angela Puente; Annalisa Berzigotti; Pierre Emmanuel Rautou; Candid Villanueva; Pere Ginès; J C Garcia-Pagan; Bogdan Procopet; Cristophe Bureau; Agustin Albillos; Sven Francque; Thomas Reiberger; Filippo Schepis; Isabel Graupera; Virginia Hernandez-Gea
Journal:  Clin Gastroenterol Hepatol       Date:  2021-10-21       Impact factor: 13.576

Review 7.  Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis.

Authors:  Guadalupe Garcia-Tsao; Scott Friedman; John Iredale; Massimo Pinzani
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

8.  Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis.

Authors:  José Ferrusquía-Acosta; Octavi Bassegoda; Laura Turco; Enric Reverter; Monica Pellone; Marcello Bianchini; Valeria Pérez-Campuzano; Enric Ripoll; Ángeles García-Criado; Isabel Graupera; Juan Carlos García-Pagán; Filippo Schepis; Marco Senzolo; Virginia Hernández-Gea
Journal:  J Hepatol       Date:  2020-10-14       Impact factor: 25.083

9.  Can We Rely on Changes in HVPG in Patients with Cirrhosis?

Authors:  Guadalupe Garcia-Tsao
Journal:  Hepatology       Date:  2021-10-28       Impact factor: 17.425

10.  Test-Retest Reliability and Consistency of HVPG and Impact on Trial Design: A Study in 289 Patients from 20 Randomized Controlled Trials.

Authors:  Granville J Matheson; Juan G Abraldes; Wayne Bai; Mustafa Al-Karaghouli; Jesse Stach; Shuen Sung
Journal:  Hepatology       Date:  2021-08-15       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.